Table 1.

Coding, indications, and composition of the used AIT products and vaccines.

Code name	Product name	Vendor	Indication	Contained Antigen(s)	Adjuvant
AIT product 1	Pollinex® Quattro BEH	Bencard, Allergy	Allergy treatment	300, 800, or 2000 standardized units (SU)/ml tree pollen allergoids (birch, elder, hazel) adsorbed to L-Tyrosine	50 µg MPLA per 1.5 ml syringe
AIT product 2	ALLERGOVIT® BEH	Allergopharma	Allergy treatment	10000 therapeutic units (TE)/ml tree pollen allergoids (35% birch, 30% elder, 35% hazel)	Aluminum hydroxide
AIT product 3	Purethal® Spring trees I	HAL Allergy	Allergy treatment	20000 arbitrary units (AUM)/ml tree pollen allergoids (33% birch, 33% elder, 33% hazel)	0.55 mg aluminum hydroxide per 3 ml solution
AIT product 4	Allergovit® birch	Allergopharma	Allergy treatment	10000 TE/ml birch pollen allergoids	Aluminum hydroxide
AIT product 5	Purethal® birch	HAL Allergy	Allergy treatment	20000 AUM/ml birch pollen allergoids	0.55 mg aluminum hydroxide per 3 ml solution
Vaccine 1	Fendrix®	GlaxoSmithKline	Prevention of hepatitis B infection	20 µg Hepatitis B surface antigen per 0.5 ml syringe	AS04 (50 µg MPLA & adsorbed to 0.5 mg aluminum phosphate per 0.5 ml syringe)
Vaccine 2	Cervarix®	GlaxoSmithKline	Prevention of cervical cancer	40 µg recombinant human papilloma virus L1 proteins per 0.5 ml syringe	AS04 (50 µg MPLA & adsorbed to 0.5 mg aluminum phosphate per 0.5 ml syringe)

BEH, birch; elder, hazel; SU, standardized units; TE, therapeutic units; AUM, arbitrary units; MPLA, monophosphoryl lipid A; AS, adjuvant system.